- Home
- PEPG vs TIL Comparison
PEPG vs TIL Comparison
Compare PEPG & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- TIL
- Stock Information
- Founded
- PEPG 2018
- TIL 2018
- Country
- PEPG United States
- TIL United States
- Employees
- PEPG N/A
- TIL N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- PEPG Health Care
- TIL Health Care
- Exchange
- PEPG Nasdaq
- TIL Nasdaq
- Market Cap
- PEPG 118.3M
- TIL 134.5M
- IPO Year
- PEPG 2022
- TIL 2021
- Fundamental
- Price
- PEPG $2.08
- TIL $19.61
- Analyst Decision
- PEPG Buy
- TIL Strong Buy
- Analyst Count
- PEPG 3
- TIL 4
- Target Price
- PEPG $14.67
- TIL $114.00
- AVG Volume (30 Days)
- PEPG 158.0K
- TIL 103.6K
- Earning Date
- PEPG 03-05-2025
- TIL 11-13-2024
- Dividend Yield
- PEPG N/A
- TIL N/A
- EPS Growth
- PEPG N/A
- TIL N/A
- EPS
- PEPG N/A
- TIL N/A
- Revenue
- PEPG N/A
- TIL N/A
- Revenue This Year
- PEPG N/A
- TIL N/A
- Revenue Next Year
- PEPG N/A
- TIL $2.64
- P/E Ratio
- PEPG N/A
- TIL N/A
- Revenue Growth
- PEPG N/A
- TIL N/A
- 52 Week Low
- PEPG $2.09
- TIL $9.62
- 52 Week High
- PEPG $19.30
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- PEPG 18.60
- TIL 42.58
- Support Level
- PEPG $3.69
- TIL $18.56
- Resistance Level
- PEPG $4.48
- TIL $22.00
- Average True Range (ATR)
- PEPG 0.27
- TIL 2.05
- MACD
- PEPG -0.09
- TIL 0.27
- Stochastic Oscillator
- PEPG 0.25
- TIL 13.49
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.